BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 18619797)

  • 1. Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies.
    Groenwold RH; Hak E; Hoes AW
    J Clin Epidemiol; 2009 Jan; 62(1):22-8. PubMed ID: 18619797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods to assess intended effects of drug treatment in observational studies are reviewed.
    Klungel OH; Martens EP; Psaty BM; Grobbee DE; Sullivan SD; Stricker BH; Leufkens HG; de Boer A
    J Clin Epidemiol; 2004 Dec; 57(12):1223-31. PubMed ID: 15617947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An application of propensity score matching using claims data.
    Seeger JD; Williams PL; Walker AM
    Pharmacoepidemiol Drug Saf; 2005 Jul; 14(7):465-76. PubMed ID: 15651087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiologic studies: pitfalls in interpretation.
    Westhoff CL
    Dialogues Contracept; 1995; 4(5):5-6, 8. PubMed ID: 12288680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A sensitivity analysis using information about measured confounders yielded improved uncertainty assessments for unmeasured confounding.
    McCandless LC; Gustafson P; Levy AR
    J Clin Epidemiol; 2008 Mar; 61(3):247-55. PubMed ID: 18226747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods to adjust for bias and confounding in critical care health services research involving observational data.
    Wunsch H; Linde-Zwirble WT; Angus DC
    J Crit Care; 2006 Mar; 21(1):1-7. PubMed ID: 16616616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of the objectives of and the approaches to propensity score analyses.
    Heinze G; Jüni P
    Eur Heart J; 2011 Jul; 32(14):1704-8. PubMed ID: 21362706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Interpretation of epidemiologic studies. Type of study, elements of bias, causality].
    Touzet S; Colin C
    Rev Prat; 1999 Oct; 49(16):1797-804. PubMed ID: 10578612
    [No Abstract]   [Full Text] [Related]  

  • 9. Practical application of nonrandomized research to patient care: a case study of nesiritide.
    Winegardner ML; Reaume KT; Dabaja GS; Kalus JS
    Pharmacotherapy; 2007 Jan; 27(1):143-51. PubMed ID: 17192168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bias.
    Delgado-Rodríguez M; Llorca J
    J Epidemiol Community Health; 2004 Aug; 58(8):635-41. PubMed ID: 15252064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic reviews incorporating evidence from nonrandomized study designs: reasons for caution when estimating health effects.
    Reeves BC; van Binsbergen J; van Weel C
    Eur J Clin Nutr; 2005 Aug; 59 Suppl 1():S155-61. PubMed ID: 16052184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors.
    Nelson JC; Jackson ML; Weiss NS; Jackson LA
    J Clin Epidemiol; 2009 Jul; 62(7):687-94. PubMed ID: 19124221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pooling of confounders did not induce residual confounding in influenza vaccination studies.
    Groenwold RH; Hak E; Hoes AW
    Ann Epidemiol; 2009 Jun; 19(6):432-6. PubMed ID: 19460673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian perspectives for epidemiologic research: III. Bias analysis via missing-data methods.
    Greenland S
    Int J Epidemiol; 2009 Dec; 38(6):1662-73. PubMed ID: 19744933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Roaming through methodology. XIII. Matching as a rule is not useful].
    Verbeek AL
    Ned Tijdschr Geneeskd; 1999 May; 143(20):1037-40. PubMed ID: 10368730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confounding in evaluating the effectiveness of influenza vaccine.
    Mori M; Oura A; Ohnishi H; Washio M
    Vaccine; 2008 Nov; 26(50):6459-61. PubMed ID: 18573295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic differences in treatment effect estimates between propensity score methods and logistic regression.
    Martens EP; Pestman WR; de Boer A; Belitser SV; Klungel OH
    Int J Epidemiol; 2008 Oct; 37(5):1142-7. PubMed ID: 18453634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving participant selection in disease management programmes: insights gained from propensity score stratification.
    Linden A; Adams JL
    J Eval Clin Pract; 2008 Oct; 14(5):914-8. PubMed ID: 19018926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weighted nonparametric maximum likelihood estimate of a mixing distribution in nonrandomized clinical trials.
    Liu C; Xie J; Zhang Y
    Stat Med; 2007 Dec; 26(29):5303-19. PubMed ID: 17497612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A primer in epidemiologic methodology.
    Weigler BJ
    Comp Med; 2001 Jun; 51(3):208-17. PubMed ID: 11924774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.